Safety Data Sheets (SDS)

2
PermaBASE
®
Cement Board Products
PRECAUTIONARY STATEMENTS
PREVENTION
Obtain special instructions before use.
Do not handle until all safety precautions have been read and understood.
Do not breathe dust.
Use personal protective equipment as required. (See Section 8)
Use engineering controls and wet methods to minimize dust.
RESPONSE
If breathing is dicult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
If on skin, wash with plenty of soap and water. If skin irritation occurs, get medical attention.
If in eyes, rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Get medical attention if exposed or concerned.
STORAGE
Store material in a cool, dry, ventilated area, away from excessive heat or sunlight.
DISPOSAL
Dispose of material in accordance with federal, state, and local regulations.
SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS
CHEMICAL NAME COMMON NAME/SYNONYM IDENTIFIERS/CAS NUMBER % (WEIGHT) IMPURITIES
Silicon Dioxide (SiO2) Sand, quartz 14808-60-7 <50
Mixture-calcium and
aluminum silicates
Portland Cement 65997-15-1 <25
Crystalline silica
(CAS # 14808-60-7)
Mixture-silicates,
aluminates
Pozzolan, y ash 68131-74-8 <25
Crystalline silica
(CAS # 14808-60-7)
Mixture-silicates,
aluminates
High Alumina Cement 65997-16-2 <6
Crystalline silica
(CAS # 14808-60-7)
Mixture-calcium, aluminum
silicates, amorphous silica
Fiberglass scrim or
berglass mat laminate
65997-17-3 <5
Calcium Hydroxide Hydrated lime 1395-62-0 <2
Crystalline silica
(CAS # 14808-60-7)
SECTION 4: FIRST-AID MEASURES
INHALATION
Remove exposed individual to fresh air immediately. If breathing diculty persists, seek medical attention.
EYE CONTACT
Do not rub or scratch eyes. Immediately ush eyes with water for 15 minutes. Remove contact lenses (if applicable). Seek medical attention if
irritation persists.
SKIN CONTACT
Flush and wash skin with soap and water. Utilize lotions to alleviate dryness if present. Seek medical attention if irritation persists.
INGESTION
This product is not expected to be hazardous and no harmful eects are expected upon ingestion of small amounts. Larger amounts may cause
abdominal discomfort or possible obstruction of the digestive tract. Seek medical attention if problems persist.
MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE
Pre-existing upper respiratory and lung diseases such as, but not limited to, bronchitis, emphysema and asthma. Pre-existing skin diseases such
as, but not limited to, rashes and dermatitis.
MOST IMPORTANT SYMPTOMS/EFFECTS, ACUTE AND DELAYED:
See Section 11 - Toxicological Information
SAFETY DATA SHEET
SDS01504